Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Nuance Communications Inc is a software-application business based in the US. Nuance Communications shares (NUAN) are listed on the NASDAQ and all prices are listed in US Dollars. Nuance Communications employs 7,100 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$55.11|
|52-week range||$31.05 - $55.35|
|50-day moving average||$55.16|
|200-day moving average||$53.87|
|Wall St. target price||$57.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.11%|
|1 month (2021-09-24)||-0.20%|
|3 months (2021-07-23)||-0.07%|
|6 months (2021-04-23)||3.80%|
|1 year (2020-10-23)||60.67%|
|2 years (2019-10-24)||256.70%|
|3 years (2018-10-24)||230.85%|
|5 years (2016-10-24)||296.50%|
Valuing Nuance Communications stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nuance Communications's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nuance Communications's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 13.72. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nuance Communications's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nuance Communications's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $277 million.
The EBITDA is a measure of a Nuance Communications's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.5 billion|
|Operating margin TTM||10.63%|
|Gross profit TTM||$867.8 million|
|Return on assets TTM||2.9%|
|Return on equity TTM||0.2%|
|Market capitalisation||$17.4 billion|
TTM: trailing 12 months
There are currently 36.6 million Nuance Communications shares held short by investors – that's known as Nuance Communications's "short interest". This figure is 4.5% up from 35.0 million last month.
There are a few different ways that this level of interest in shorting Nuance Communications shares can be evaluated.
Nuance Communications's "short interest ratio" (SIR) is the quantity of Nuance Communications shares currently shorted divided by the average quantity of Nuance Communications shares traded daily (recently around 3.0 million). Nuance Communications's SIR currently stands at 12.41. In other words for every 100,000 Nuance Communications shares traded daily on the market, roughly 12410 shares are currently held short.
However Nuance Communications's short interest can also be evaluated against the total number of Nuance Communications shares, or, against the total number of tradable Nuance Communications shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nuance Communications's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Nuance Communications shares in existence, roughly 120 shares are currently held short) or 0.1171% of the tradable shares (for every 100,000 tradable Nuance Communications shares, roughly 117 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Nuance Communications.
Find out more about how you can short Nuance Communications stock.
We're not expecting Nuance Communications to pay a dividend over the next 12 months.
Nuance Communications's shares were split on a 1155:1000 basis on 1 October 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1155 shares. This wouldn't directly have changed the overall worth of your Nuance Communications shares – just the quantity. However, indirectly, the new 13.4% lower share price could have impacted the market appetite for Nuance Communications shares which in turn could have impacted Nuance Communications's share price.
Over the last 12 months, Nuance Communications's shares have ranged in value from as little as $31.05 up to $55.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nuance Communications's is 1.2127. This would suggest that Nuance Communications's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, Web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.